Health Care Weekly Preview from ML Strategies – April 2018 #2

Mintz - Health Care Viewpoints

The President was slated to speak on drug prices this week in what was a highly anticipated event. Yesterday, word got out that it would be postponed to a date to be determined. The health of the HHS Secretary certainly played a factor in the delay. It forces stakeholders back to the waiting game, try as they may to get a sense of which direction the Administration may go. The speech was expected to coincide with a Request for Information of some kind that is currently pending at OMB. The “HHS Strategy to Lower Drug Prices and Reduce Out-of-Pocket Costs,” while not economically significant, will certainly make people nervous until they see direction from the Administration.

Please see full Publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz - Health Care Viewpoints | Attorney Advertising

Written by:

Mintz - Health Care Viewpoints

Mintz - Health Care Viewpoints on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.